BioXcel Therapeutics
BTAI
#9513
Rank
ยฃ20.65 M
Marketcap
ยฃ0.51
Share price
2.37%
Change (1 day)
-86.91%
Change (1 year)

Revenue for BioXcel Therapeutics (BTAI)

Revenue in 2024 (TTM): ยฃ1.9 Million

According to BioXcel Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ1.84 Million. In 2023 the company made a revenue of ยฃ1.08 Million an increase over the revenue in the year 2022 that were of ยฃ0.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioXcel Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ1.9 M76.16%
2023 ยฃ1.08 M249.46%
2022 ยฃ0.3 M
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA